Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study

Archives of Dermatology

Volumn 147, Issue 5, 2011, Pages 540-546

  Chren, Mary Margaret ^a,b   Torres, Jeanette S ^a   Stuart, Sarah E ^a   Bertenthal, Daniel ^a   Labrador, Remedios J ^a   Boscardin, W John ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CHEMOSURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ELECTRODESSICATION AND CURETTAGE; EXCISION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONMELANOMA SKIN CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN CANCER; SKIN SURGERY; TUMOR RECURRENCE;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CURETTAGE; ELECTROSURGERY; FEMALE; HUMANS; MALE; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 79956128912     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.109     Document Type: Article

References (16)

1. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ. 2004;329(7468):705.
2. Chren MM, Sahay AP, Sands LP, et al. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care. 2004;42 (10):1019-1026. (Pubitemid 39530798)
3. Do D. Mohs micrographic surgery for basal cell carcinoma of the face. Arch Dermatol. 2009;145(12):1428-1430.
4. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-233. (Pubitemid 126433231)
5. Charlson ME, Pompei PP, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
6. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34(1):73-84.
7. Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007;127(6):1351-1357. (Pubitemid 46762993)
8. Swanson NA, Grekin RC, Baker SR. Mohs surgery: techniques, indications, and applications in head and neck surgery. Head Neck Surg. 1983;6(2):683-692.
9. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: basal cell and squamous cell skin cancers [registration required]. http://www.nccn.org/index.asp. Accessed May 18, 2010.
10. Smeets NW, Kuijpers DI, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol. 2004;151(1):141-147. (Pubitemid 39061291)
11. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135(10):1177-1183. (Pubitemid 29493277)
12. Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008;9(12):1149-1156.
13. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673-685.
14. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987;123(3):340-344. (Pubitemid 17024671)
15. Nguyen P, Vin-Christian K, Ming ME, Berger T. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol. 2002;138(6):758-763. (Pubitemid 34625520)
16. Otley CC. Immunosuppression and skin cancer: pathogenetic insights, therapeutic challenges, and opportunities for innovation. Arch Dermatol. 2002;138(6):827-828. (Pubitemid 34625530)